A carregar...
MAPK- and AKT-activated thyroid cancers are sensitive to group I PAK inhibition
The number of individuals who succumb to thyroid cancer has been increasing and those who are refractory to standard care have limited therapeutic options, highlighting the importance of developing new treatments for patients with aggressive forms of the disease. Mutational activation of MAPK signal...
Na minha lista:
| Publicado no: | Endocr Relat Cancer |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7062234/ https://ncbi.nlm.nih.gov/pubmed/31146260 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-19-0188 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|